Home » Newsletters » BioWorld Science

BioWorld Science

June 15, 1999

View Archived Issues

Final analysis of Lyon Diet Heart Study reported

Modified beta-lactoglobulin decreases vaginal transmission of SIV

ChemRx and DuPont sign chemistry collaboration

Follow-up data presented for Bexxar cancer therapy

Mechanism underlying Oxigene's tumor vascular targeting agent revealed

FDA approves initiation of clinical trial of strep vaccine

Cytogen updates Canadian product rights

Campath-1H trial results presented in Barcelona

Lamictal approved in Canada for Lennox-Gastaut syndrome

Ares-Serono will acquire marketing rights to Crinone

Phase I results on adenoviral-p53 therapy in non-small cell lung cancer

Fujisawa describes preparation and use of adenosine receptor antagonists

New PTK inhibitors developed at Bristol-Myers Squibb

Antiallergic phenothiazines patented by Eisai investigators

Substantially pure (S)-(+)-enantiomer form of ETA antagonist prepared at Pfizer

Warner-Lambert describes agents interacting with Ca2+ binding sites

Proteasome inhibitor CVT-634 prevents ischemic neuronal injury in rat model

Chemokine peptides designed at NeoRx useful for inflammatory disorders

Free radical-scavenging compound SPBN: therapeutic efficacy and potential complications

Antiinflammatory and immunosuppressive compounds related to leflunomide

Nisshin Flour Milling studies agents for diabetic complications

Abbott and Cephalon sign collaborative agreement for Gabitril

Trovan use also limited in Canada

Dendritic cell therapy: a novel treatment strategy for breast and ovarian cancers

Intranasal civamide evaluated for acute treatment of migraine

Treatment with MMP inhibitor attenuates ischemic damage in infarcted mice

Prophylaxis of migraine with oral dotarizine

Bisoprolol receives first European approval for chronic heart failure

Histamine desensitization in the Rx of chronic cluster headache

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...